
Dr. Reddy’s unveils cancer drug in U.S.
September 8, 2022
Lenalidomide capsules, a generic version of the popular multiple myeloma drug Revlimid, have been introduced to the US market, according to pharma giant Dr Reddy’s Laboratories, which on Wednesday informed the stock markets. According to Dr. Reddy’s, with this volume-restricted









